These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 12167586

  • 1. Mechanisms of secondary hyperparathyroidism.
    Silver J, Kilav R, Naveh-Many T.
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [Abstract] [Full Text] [Related]

  • 2. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
    Silver J, Levi R.
    Kidney Int Suppl; 2005 Jun; (95):S8-12. PubMed ID: 15882315
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of parathyroid dysfunction in end-stage kidney disease.
    Levi R, Silver J.
    Pediatr Nephrol; 2005 Mar; 20(3):342-5. PubMed ID: 15549412
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve.
    Bas S, Aguilera-Tejero E, Bas A, Estepa JC, Lopez I, Madueño JA, Rodriguez M.
    J Endocrinol; 2005 Jan; 184(1):241-7. PubMed ID: 15642800
    [Abstract] [Full Text] [Related]

  • 6. Cellular and molecular mechanisms of secondary hyperparathyroidism.
    Silver J, Levi R.
    Clin Nephrol; 2005 Feb; 63(2):119-26. PubMed ID: 15730054
    [Abstract] [Full Text] [Related]

  • 7. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
    Cañadillas S, Canalejo A, Santamaría R, Rodríguez ME, Estepa JC, Martín-Malo A, Bravo J, Ramos B, Aguilera-Tejero E, Rodríguez M, Almadén Y.
    J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 9. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
    Naveh-Many T, Rahamimov R, Livni N, Silver J.
    J Clin Invest; 1995 Oct; 96(4):1786-93. PubMed ID: 7560070
    [Abstract] [Full Text] [Related]

  • 10. Phosphate and the parathyroid.
    Silver J, Naveh-Many T.
    Kidney Int; 2009 May; 75(9):898-905. PubMed ID: 19129794
    [Abstract] [Full Text] [Related]

  • 11. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 12. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure.
    Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S42-7. PubMed ID: 8608662
    [Abstract] [Full Text] [Related]

  • 13. The genetic background of uremic secondary hyperparathyroidism.
    Aucella F, Morrone L, Stallone C, Gesualdo L.
    J Nephrol; 2005 Nov; 18(5):537-47. PubMed ID: 16299679
    [Abstract] [Full Text] [Related]

  • 14. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells.
    Nielsen PK, Feldt-Rasmussen U, Olgaard K.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1762-8. PubMed ID: 8918619
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of secondary hyperparathyroidism.
    Silver J.
    Nephrol Dial Transplant; 2000 Sep; 15 Suppl 5():2-7. PubMed ID: 11073267
    [No Abstract] [Full Text] [Related]

  • 16. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A.
    J Nephrol; 2005 Sep; 18(1):5-8. PubMed ID: 15772917
    [Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
    Gohda T, Shou I, Fukui M, Funabiki K, Horikoshi S, Shirato I, Tomino Y.
    Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
    [Abstract] [Full Text] [Related]

  • 18. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism].
    Fernández Martín JL, González Suárez I, Cannata Andía JB.
    Nefrologia; 2003 Jun; 23 Suppl 2():7-11. PubMed ID: 12778846
    [Abstract] [Full Text] [Related]

  • 19. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
    Nechama M, Ben-Dov IZ, Silver J, Naveh-Many T.
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F795-800. PubMed ID: 19129257
    [Abstract] [Full Text] [Related]

  • 20. The molecular basis of secondary hyperparathyroidism in chronic renal failure.
    Rahamimov R, Silver J.
    Isr J Med Sci; 1994 Jan; 30(1):26-31. PubMed ID: 8138394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.